BPI Labs, which holds both FDA drug manufacturer registration and 503B designation, may have more regulatory flexibility than pure 503B facilities
They become the product for everyone," the CEO said
Presentation of 2 cases and review of the literature
A follow-up extension study found that participants regained approximately two-thirds of lost weight within one year of stopping treatment, highlighting the importance of sustained therapy (Wilding et al., 2022, PMID: 35441470)
Patients should track their symptoms, including: Frequency and severity of gas Associated symptoms like sulfur burps Impact on daily activities Effectiveness of attempted remedies Special attention is needed for patients with: Kidney problems, as dehydration from digestive issues can worsen kidney function Diabetes, as digestive issues may affect blood sugar management Planned surgical procedures requiring anesthesia Patients experiencing persistent gas alongside acid reflux should note that about 2% of users report these combined symptoms, particularly at lower doses
Take fiber supplements 2 hours away from Retatrutide injection to avoid interference